Cart
sales@molnova.com
8-Azabicyclo[3.2.1]octan-3-one, 8-methyl
CAS No. 1515-26-0
8-Azabicyclo[3.2.1]octan-3-one, 8-methyl( —— )
Catalog No. M22279 CAS No. 1515-26-0
8-Azabicyclo[3.2.1]octan-3-one, 8-methyl targets the MAS-related GPR member X1 (human).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 272 | Get Quote |
|
| 10MG | 408 | Get Quote |
|
| 25MG | 735 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name8-Azabicyclo[3.2.1]octan-3-one, 8-methyl
-
NoteResearch use only, not for human use.
-
Brief Description8-Azabicyclo[3.2.1]octan-3-one, 8-methyl targets the MAS-related GPR member X1 (human).
-
Description8-Azabicyclo[3.2.1]octan-3-one, 8-methyl targets the MAS-related GPR member X1 (human).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorMAS-related GPR member X1 (human)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1515-26-0
-
Formula Weight154.21
-
Molecular FormulaC8H14N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN1C2CCC1C\C(C2)=N/O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Chrysophanol8-O-β-D-...
Chrysophanol8-O-β-D-(6'-O-malonyl)glucoside
-
HIF-1 alpha 556-574
HIF-1 alpha (556-574) is a hypoxia-inducible factor-1 19-mer fragment. HIF-1 functions as master regulator of response to oxygen homeostasis. Hypoxia-induced gene expression is initiated when HIF-1subunit is stabilized in response to a lack of oxygen. This part of HIF-1 binds to the von Hippel-Lindau factor (VHL) an E3 ubiquitin ligase, and the proline 564 is absolutely vital to the binding process.
-
VULM 1457
VULM 1457 is a potent ACAT inhibitor. VULM 1457 has remarkable hypolipidaemic activity and improves the overall myocardial ischaemia-reperfusion injury outcomes.
